(CAG) ConAgra Foods - Ratings and Ratios
Frozen Meals, Shelf-Stable Entrees, Snacks, Baking Mixes, Whipped Toppings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.07% |
| Yield on Cost 5y | 4.87% |
| Yield CAGR 5y | 11.25% |
| Payout Consistency | 94.2% |
| Payout Ratio | 67.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.0% |
| Value at Risk 5%th | 38.8% |
| Relative Tail Risk | -1.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.59 |
| Alpha | -38.57 |
| CAGR/Max DD | -0.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.313 |
| Beta | 0.091 |
| Beta Downside | -0.003 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.41% |
| Mean DD | 26.93% |
| Median DD | 26.31% |
Description: CAG ConAgra Foods November 04, 2025
Conagra Brands, Inc. (NYSE:CAG) is a U.S.–based consumer packaged goods company that sells a broad portfolio of shelf-stable, refrigerated, and frozen foods across four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. Its brands-including Birds Eye, Marie Callender’s, Duncan Hines, Healthy Choice, Slim Jim, Reddi-Wip, Angies, and BOOMCHICKAPOP-are distributed through grocery retailers, club stores, e-commerce platforms, and foodservice outlets, with the International segment extending these offerings outside the United States.
Key performance indicators to watch include the 12-month trailing same-store sales growth in the Grocery & Snacks segment (historically 2-4% YoY) and the contribution margin expansion from the Refrigerated & Frozen segment, which has benefited from higher pricing power amid rising commodity costs. Macro drivers such as U.S. consumer discretionary spending trends, inflation-adjusted food price indices, and the shift toward “convenient at-home” meals continue to shape demand, while the ongoing supply-chain bottlenecks in cold-storage logistics present both risk and upside for margin improvement.
For a deeper, data-driven assessment of Conagra’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (66.5m TTM) > 0 and > 6% of Revenue (6% = 832.0m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -0.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -2.84% (prev -11.35%; Δ 8.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 1.54b > Net Income 66.5m (YES >=105%, WARN >=100%) |
| Net Debt (1.12b) to EBITDA (1.11b) ratio: 1.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (478.8m) change vs 12m ago -0.10% (target <= -2.0% for YES) |
| Gross Margin 24.48% (prev 27.24%; Δ -2.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.15% (prev 56.75%; Δ 14.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.19 (EBITDA TTM 1.11b / Interest Expense TTM 488.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.48
| (A) -0.02 = (Total Current Assets 3.23b - Total Current Liabilities 3.62b) / Total Assets 17.96b |
| (B) 0.38 = Retained Earnings (Balance) 6.76b / Total Assets 17.96b |
| (C) 0.05 = EBIT TTM 1.07b / Avg Total Assets 19.49b |
| (D) 0.98 = Book Value of Equity 9.70b / Total Liabilities 9.87b |
| Total Rating: 2.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.61
| 1. Piotroski 3.50pt |
| 2. FCF Yield 11.84% |
| 3. FCF Margin 8.23% |
| 4. Debt/Equity 0.14 |
| 5. Debt/Ebitda 1.01 |
| 6. ROIC - WACC (= 0.31)% |
| 7. RoE 0.77% |
| 8. Rev. Trend 26.20% |
| 9. EPS Trend -52.23% |
What is the price of CAG shares?
Over the past week, the price has changed by -2.25%, over one month by -0.29%, over three months by -4.50% and over the past year by -30.82%.
Is CAG a buy, sell or hold?
- Strong Buy: 0
- Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.9 | 14.9% |
| Analysts Target Price | 19.9 | 14.9% |
| ValueRay Target Price | 16.2 | -6.9% |
CAG Fundamental Data Overview December 20, 2025
P/E Trailing = 10.0565
P/E Forward = 10.1523
P/S = 0.7436
P/B = 0.9614
P/EG = 11.2747
Beta = -0.016
Revenue TTM = 13.87b USD
EBIT TTM = 1.07b USD
EBITDA TTM = 1.11b USD
Long Term Debt = 6.23b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.16b USD (from shortTermDebt, last quarter)
Debt = 1.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.12b USD (from netDebt column, last quarter)
Enterprise Value = 9.63b USD (8.51b + Debt 1.16b - CCE 46.6m)
Interest Coverage Ratio = 2.19 (Ebit TTM 1.07b / Interest Expense TTM 488.6m)
FCF Yield = 11.84% (FCF TTM 1.14b / Enterprise Value 9.63b)
FCF Margin = 8.23% (FCF TTM 1.14b / Revenue TTM 13.87b)
Net Margin = 0.48% (Net Income TTM 66.5m / Revenue TTM 13.87b)
Gross Margin = 24.48% ((Revenue TTM 13.87b - Cost of Revenue TTM 10.47b) / Revenue TTM)
Gross Margin QoQ = 23.82% (prev 24.33%)
Tobins Q-Ratio = 0.54 (Enterprise Value 9.63b / Total Assets 17.96b)
Interest Expense / Debt = 16.29% (Interest Expense 189.8m / Debt 1.16b)
Taxrate = -36.29% (negative due to tax credits) (132.9m / -366.2m)
NOPAT = 1.46b (EBIT 1.07b * (1 - -36.29%)) [negative tax rate / tax credits]
Current Ratio = 0.89 (Total Current Assets 3.23b / Total Current Liabilities 3.62b)
Debt / Equity = 0.14 (Debt 1.16b / totalStockholderEquity, last quarter 8.09b)
Debt / EBITDA = 1.01 (Net Debt 1.12b / EBITDA 1.11b)
Debt / FCF = 0.98 (Net Debt 1.12b / FCF TTM 1.14b)
Total Stockholder Equity = 8.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.37% (Net Income 66.5m / Total Assets 17.96b)
RoE = 0.77% (Net Income TTM 66.5m / Total Stockholder Equity 8.68b)
RoCE = 7.18% (EBIT 1.07b / Capital Employed (Equity 8.68b + L.T.Debt 6.23b))
RoIC = 8.57% (NOPAT 1.46b / Invested Capital 17.04b)
WACC = 8.26% (E(8.51b)/V(9.68b) * Re(6.35%) + D(1.16b)/V(9.68b) * Rd(16.29%) * (1-Tc(-0.36)))
Discount Rate = 6.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.10%
[DCF Debug] Terminal Value 79.86% ; FCFE base≈1.27b ; Y1≈1.42b ; Y5≈1.90b
Fair Price DCF = 68.80 (DCF Value 32.91b / Shares Outstanding 478.4m; 5y FCF grow 14.02% → 3.0% )
EPS Correlation: -52.23 | EPS CAGR: -15.52% | SUE: 0.0 | # QB: 0
Revenue Correlation: 26.20 | Revenue CAGR: 19.10% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-02-28): EPS=0.44 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-05-31): EPS=1.85 | Chg30d=+0.025 | Revisions Net=-1 | Growth EPS=-23.0% | Growth Revenue=-3.3%
EPS next Year (2027-05-31): EPS=1.85 | Chg30d=-0.017 | Revisions Net=-4 | Growth EPS=+5.7% | Growth Revenue=-0.8%
Additional Sources for CAG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle